Majedie Asset Management’s Pfizer PFE Stock Holding History

Majedie Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$10.1M	Buy	195,212 +42,073	+27%	+$2.18M	0.83%	36
2021 Q4	$9.05M	Sell	153,139 -76,725	-33%	-$3.8M	0.69%	47
2021 Q3	$9.89M	Sell	229,864 -128,839	-36%	-$5.71M	0.75%	44
2021 Q2	$14.1M	Buy	358,703 +45,092	+14%	+$1.75M	0.92%	28
2021 Q1	$11.4M	Buy	313,611 +166,551	+113%	+$5.91M	0.82%	39
2020 Q4	$5.42M	Sell	147,060 -74,125	-34%	-$2.72M	0.42%	64
2020 Q3	$7.71M	Sell	221,185 -7,862	-3%	-$276K	0.57%	41
2020 Q2	$7.11M	Sell	229,047 -99,637	-30%	-$3.38M	0.54%	42
2020 Q1	$10.2M	Buy	328,684 +137,378	+72%	+$4.68M	0.94%	22
2019 Q4	$7.12M	Buy	191,306 +6,930	+4%	+$247K	0.52%	41
2019 Q3	$6.29M	Sell	184,376 -62,691	-25%	-$2.28M	0.53%	41
2019 Q2	$10.2M	Sell	247,067 -791	-0.3%	-$31.4K	0.78%	30
2019 Q1	$9.99M	Sell	247,858 -16,633	-6%	-$666K	0.71%	35
2018 Q4	$11.2M	Sell	264,491 -35,683	-12%	-$1.48M	0.83%	32
2018 Q3	$12.6M	Buy	300,174 +10,738	+4%	+$413K	0.95%	28
2018 Q2	$9.96M	Sell	289,436 -5,041	-2%	-$172K	0.77%	31
2018 Q1	$9.92M	Sell	294,477 -72,163	-20%	-$2.48M	0.9%	29
2017 Q4	$12.6M	Sell	366,640 -27,533	-7%	-$939K	1.06%	23
2017 Q3	$13.4M	Buy	394,173 +38,984	+11%	+$1.25M	1.09%	23
2017 Q2	$11.3M	Buy	355,189 +25,856	+8%	+$815K	1.07%	25
2017 Q1	$10.7M	Buy	+329,333	New	+$10.4M	1.14%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Majedie Asset Management's PFE Position: Q1 2022 in Review

Majedie Asset Management increased its Pfizer (PFE) stake by 27% in Q1 2022, buying an estimated $2.18M and bringing the position to 195,212 shares worth $10.1M. The position accounts for 0.83% of the portfolio, ranked #36.

Majedie Asset Management first reported a position in PFE in Q1 2017 and has held it in 21 quarters since. The position peaked at $14.1M in Q2 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Majedie Asset Management held 195,212 shares of Pfizer worth $10.1M as of Q1 2022.
Majedie Asset Management bought 42,073 Pfizer shares in Q1 2022, an estimated $2.18M.
Pfizer made up 0.83% of Majedie Asset Management's portfolio in Q1 2022, its #36 holding.
Majedie Asset Management first reported a position in Pfizer in Q1 2017 and has held it in 21 quarters since.
Majedie Asset Management's Pfizer position peaked at $14.1M in Q2 2021.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Majedie Asset Management's 13F filing for Q1 2022, filed 16 May 2022.